home.social

#rolontis — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #rolontis, aggregated by home.social.

  1. Yonhap Infomax News @[email protected] ·

    Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #hanmipharmaceutical #rolontis #tabukpharmaceuticals #neutropenia #middleeastmarket
  2. Yonhap Infomax News @[email protected] ·

    Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #hanmipharmaceutical #rolontis #tabukpharmaceuticals #neutropenia #middleeastmarket
  3. Yonhap Infomax News @[email protected] ·

    Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #stockmarket #bonds #securities #banking #financialmarkets #economics
  4. Yonhap Infomax News @[email protected] ·

    Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.
    #YonhapInfomax #HanmiPharmaceutical #Rolontis #TabukPharmaceuticals #Neutropenia #MiddleEastMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #hanmipharmaceutical #rolontis #tabukpharmaceuticals #neutropenia #middleeastmarket